Stryker Corporation

SYK 
(NYSE) 
 
$ 197.80 <%= Resources.Global.txtUp %>
Updated 20:19:18
Change % 0.72% Stock price increasing
Change 1.41 Stock price increasing
Volume 78,102
High $ 198.27
Low $ 196.33
Open $ 197.05
ISIN
Prev close $ 196.39
# of shares 373.11M
Market cap 73,800M USD
Intraday

Stryker Corporation
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  197.80 1.5% Stock price increasing 7.4% Stock price increasing 2.2% Stock price increasing 22.5% Stock price increasing 16.2% Stock price increasing
Powered by TradingView

News about Stryker Corporation

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Smith & Nephew PLC ORD USD0.20 1,719.24 2.1% Stock price increasing 5.5% Stock price increasing 15.7% Stock price increasing 19.8% Stock price increasing 27.2% Stock price increasing 17.4% Stock price increasing
 
Johnson & Johnson 140,34 0.4% Stock price increasing 1.2% Stock price increasing 2.3% Stock price increasing 7.6% Stock price increasing 15.7% Stock price increasing 8.7% Stock price increasing
 
Conmed Corporation 83.15 0.3% Stock price increasing 3.5% Stock price increasing 4.2% Stock price increasing 36.4% Stock price increasing 11.8% Stock price increasing 29.5% Stock price increasing
 
Integra LifeSciences Holdings .. 51.16 2.9% Stock price increasing 3.5% Stock price increasing -8.2% Stock price decreasing 7.2% Stock price increasing -23.5% Stock price decreasing 13.4% Stock price increasing
 
Zimmer Biomet Hldgs DL-01 104.36 -2.8% Stock price decreasing -0.5% Stock price decreasing -5.8% Stock price decreasing 10.4% Stock price increasing 7.4% Stock price increasing 18.3% Stock price increasing
 
NuVasive Inc 57.45 -1.9% Stock price decreasing -5.8% Stock price decreasing 4.4% Stock price increasing 10.3% Stock price increasing 4.1% Stock price increasing 15.9% Stock price increasing

Company profile

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Approximately 35% of Stryker's total revenue currently comes from outside the United States.

Peers

Instruments Last Change  
Smith & Neph.. 1,719.24 -0.1% Stock price decreasing
Johnson & Jo.. 140,34 0.6% Stock price increasing
Conmed Corpo.. 83.15 0.9% Stock price increasing
28,17,34,55,81,96,84,99,86,65
Integra Life.. 51.16 0.6% Stock price increasing
Zimmer Biome.. 104.36 -0.1% Stock price decreasing
0,0,0,0,0,0,0,0,0,0
NuVasive Inc 57.45 -0.2% Stock price decreasing
37,79,63,32,35,24,23,22,15,5

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 June 2019 20:34:29
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB2 - 2019-06-18 21:34:29 - 2019-06-18 20:34:29 - 1000 - Website: OKAY